We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · April 15, 2021

Early Intervention With Vedolizumab on Longer Term Surgery Rates in Crohn's Disease

Journal of Crohn's & colitis

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Crohn's & colitis
Early Intervention With Vedolizumab on Longer Term Surgery Rates in Crohn's Disease: Post Hoc Analysis of the GEMINI Phase 3 and Long-Term Safety Programs
J Crohns Colitis 2021 Feb 01;15(2)195-202, PS Dulai, L Peyrin-Biroulet, D Demuth, K Lasch, KA Hahn, D Lindner, H Patel, V Jairath

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading